Investing Profile

Keno Gutierrez

InvestorVC
Partner at BGV (BioGeneration Ventures)
biogenerationventures.com/tea...Amsterdam, Netherlands
Photo of Keno Gutierrez, Partner at BGV (BioGeneration Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
INSEAD Network
80 CONNECTIONS
Piper Jaffray Network
12 CONNECTIONS
cb
$100K - $1M
$500K
10
€250M
CompanyStageDateRound SizeTotal Raised
Dualyx
Series AMay 2023$43M
Series UnknownJan 2020
$43M
FundaMental Pharma
SeedNov 2022$10M
$13M
Co-investors: Mathias Frederiksen (Novartis Venture Fund)
Soteria Biotherapeutics
Series AMay 2021$42M
$42M
Co-investors: David Allison (Westlake Village BioPartners), David Morris
iOnctura
Series AJul 2020$6M
Series AJan 2020$17M
SeedJun 2017
$110M
Co-investors: Hakan Goker (M Ventures (Merck)), Roel Bulthuis (INKEF Capital), Fiona MacLaughlin (Johnson & Johnson Innovation)
ApoGen Biotechnologies
Series AAug 2018$4M
$4M
Inthera Bioscience
Series AJun 2018$5M
Series AMay 2017$11M
$20M
Co-investors: Mark Krul (Aglaia BioMedical Ventures), Nanna Luneborg (Forbion), Jasper Bos (Forbion)
Board Member Stealth mode biotech newco2022 - Present
Board Member Fibrocor Therapeutics2022 - Present
Chairman of the Board FundaMental Pharma2022 - Present
Observer (former Chairman and Board Member) dualyx2022 - Present
Board Member Stealth mode oncology biotech company2021 - Present
Partner BGV (BioGeneration Ventures)2021 - Present
Board Observer Riffyn2021 - 2021
Managing Director and Vice President M Ventures2021 - 2021
Executive Investment Director M Ventures2020 - 2021
Board Observer DNA Script2020 - 2021
Board Observer Immunitas Therapeutics2019 - 2021
Board Observer Xilio Therapeutics, Inc.2019 - 2021
Board Member ApoGen Biotechnologies, Inc.2018 - 2021
Board Member and Observer Soteria Biotherapeutics2018 - 2021
Board Member Inthera Bioscience2017 - 2021
Board Member and Observer Galecto Biotech2018 - 2020
Investment Director Healthcare M Ventures2017 - 2020
Board Member iOnctura SA2017 - 2020
Board Observer iOmx Therapeutics AG2018 - 2019
Healthcare Specialist Omega Funds2014 - 2016
Associate - Investment Banking - European Healthcare Piper Jaffray2010 - 2014
Management Consultant IMS Health2006 - 2009
Post-doctoral Research Associate and PhD Researcher Medical Research Council UK2000 - 2006
INSEAD MBA Business
University College London, National Institute for Medical Research Ph.D. Genetics and Lipid Metabolism
National Polytechnic Institute B.Sc (Hons) Pharmaceutical Chemistry